Dova Pharmaceuticals, Inc.

200 Garrett Street
Suite O
Charlottesville
Virginia
22902
United States

Tel: 434-980-8100
Fax: 434-980-8199

Show jobs for this employer

About Dova Pharmaceuticals, Inc.

Dova is a clinical-stage pharmaceutical company developing treatments for patients suffering from orphan diseases. The company’s lead compound candidate, AVA, recently completed two pivotal Phase III clinical trials for the treatment of thrombocytopenia in patients with chronic liver disease undergoing an elective procedure.
YEAR FOUNDED:
September 23, 2016
LEADERSHIP:
CEO: Alex Sapir
Board Member: Paul B. Manning
Board Member: Sean Stalfort

17 articles with Dova Pharmaceuticals, Inc.